Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
Ended Project Grant Awarded Last action
- Award ID
- R43CA232778
- Recipient
-
Nanomedtrix LLC UEI Q4SGGWL49CE4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $348,601
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $349,147.10 Federal
- -$546.45 Non-federal
- Place of performance
- Coralville, IA 52241, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$546 | $0 | |
| Amendment | -$546 | -$546 | |
| Amendment | $0 | $0 | |
| Amendment | $55,000 | $0 | |
| Original award | $295,240 | $0 |
Quick answers
Who received award R43CA232778?
R43CA232778 was awarded to Nanomedtrix LLC by National Cancer Institute (National Institutes of Health) on September 7, 2018.
How much is award R43CA232778 worth?
$348,601 has been obligated on R43CA232778: $349,147 in federal funding and -$546 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award